Support the Elizabeth and Michael Ruane Center for Endocrine Tumors
Help our committed caregivers at the Elizabeth and Michael Ruane Center for Endocrine Tumors to provide the best possible care to patients while pursuing groundbreaking new therapies. Make a gift.
Explore the Adrenal Tumors Treatment Program
Overview
The Elizabeth and Michael Ruane Center for Endocrine Tumors at Massachusetts General Hospital Cancer Center is a comprehensive program specializing in the treatment of all types of adrenal tumors:
Adrenal tumors, nonfunctional (usually benign)
Adrenal tumors, functional (usually benign)
Aldosteronoma
Cushing’s syndrome
Pheochromocytoma
Sex hormone secreting tumors
Adrenal cancer either functioning or non-functioning
Although many adrenal conditions are benign (non-cancerous), our program combines the resources of the Massachusetts General Hospital Cancer Center and the Massachusetts General Hospital’s Division of Endocrinology to provide advanced treatment for all patients.
Innovative Approaches
Our program is one of the largest and most specialized in the country in treating adrenal conditions as well as other disorders of the endocrine system. Among the innovations that make our program distinct are:
State-of-the art radiology technology for imaging adrenal tumors. These include adrenal protocol CT scans, adrenal protocol MRI scans, MIBG and octreotide radionuclide scans
The most advanced endocrinology and radiology testing to determine abnormalities of adrenal function, including bilateral adrenal vein catheterization
The most advanced surgical techniques
High volume surgical expertise
Expertise in molecular diagnostics of adrenal tumors
Advanced clinical trials to find better therapies for adrenal cancers
Imaging tests are most commonly used to evaluate and diagnose adrenal tumors. Our center features the most state-of-the art imaging facilities available, including:
Ultrasound
MRI
CT scan
PET/CT scan
MIBG scan: a specialty technology that is used to detect adrenal pheochromocytomas, extra-adrenal pheochromocytomas (paragangliomas) and metastatic pheochromocytomas. Octreotide scanning is also used for extra-adrenal paragangliomas particularly those of the head and neck
Angiography and adrenal venous sampling
Excellence in Surgical Care
Adrenal surgery has been revolutionized with the development of operative laparoscopy, a minimally invasive approach that removes the affected gland while minimizing post-operative pain and overall recovery time. Our surgeons conduct a high volume of these procedures and research has shown that outcomes improve when patients are treated in high volume facilities.
Laparoscopic surgical removal of an affected adrenal gland is the standard of care in most cases and is highly effective therapy.
Surgical Outcomes & Performance
The Center for Outcomes & Patient Safety in Surgery (COMPASS) ensures that surgical data is transparent and accessible for patients. Watch the video to view Mass General's performance for procedures to treat conditions of the adrenal, thyroid and parathyroid glands.
Multidisciplinary Patient Care
Patients in the Center for Endocrine Tumors may be cared for by a coordinated team of experts, which include:
Endocrinologists with expertise in diagnosing and treating adrenal conditions, including diagnosing those with familial genetic syndromes involving the adrenals and excess production of certain hormones. They also have experience in evaluating incidentally detected adrenal tumors so they can be followed properly long term. They provide care for patients whose adrenal glands have been removed surgically or inhibited with chemotherapy
Surgeons who are leading the way in performing and developing the most advanced surgical approaches for adrenal tumors including laparoscopic adrenalectomy and partial (cortical sparing) adrenalectomy
Diagnostic and interventional radiologists who utilize an array of medical imaging techniques including MRI, CT scans, ultrasound, adrenal vein catheterization and angiography to locate and biopsy adrenal tumors when indicated. Interventional radiologists who are capable of treating benign and malignant adrenal tumors with radiofrequency ablation in selected cases
Nuclear medicine physicians who utilize radionuclide scans such as MIBG and octreotide to image both benign and malignant
Endocrine pathologists who examine fine needle aspiration and core biopsies as well as pathological specimens of adrenal tumors. Molecular diagnostics are used when indicated
Endocrine (Medical) oncologists who prescribe the most effective chemotherapy and medications
Radiation oncologists who specialize in delivering the optimal therapeutic dose while protecting healthy tissue
Support services, including specialized nursing staff, social workers, psychiatrists, nutritionists and others
Clinical Trials
The Elizabeth and Michael Ruane Center for Endocrine Tumors is conducting clinical trials for patients with advanced endocrine cancers, and the adrenal tumor center is active in clinical research, with collaborative studies involving surgery, medical endocrinology, radiology and pathology.
Chief, Division of Gastrointestinal and Oncologic Surgery
Patient Story
Erin Morrissey
Months after college graduation, Mass General employee Erin Morrissey was diagnosed with a rare form of adrenal cancer. Erin shares more about working and living with cancer as a young adult.
Months after college graduation, Mass General employee Erin Morrissey was diagnosed with a rare form of adrenal cancer. Taking to social media to share her journey and inspire others, Erin emphasizes the importance of being your own health advocate, leaning into research, and seeking support.
Contact the Mass General Cancer Center
Contact us to make an appointment or to learn more about our programs.